Your browser doesn't support javascript.
loading
Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancer.
Fidias, Panos; Pennell, Nathan A; Boral, Anthony L; Shapiro, Geoffrey I; Skarin, Arthur T; Eder, Joseph P; Kwoh, T Jesse; Geary, Richard S; Johnson, Bruce E; Lynch, Thomas J; Supko, Jeffrey G.
Affiliation
  • Fidias P; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. pfidias2@partners.org
J Thorac Oncol ; 4(9): 1156-62, 2009 Sep.
Article in En | MEDLINE | ID: mdl-19704336
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thionucleotides / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Proto-Oncogene Proteins c-raf / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thorac Oncol Year: 2009 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thionucleotides / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Proto-Oncogene Proteins c-raf / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thorac Oncol Year: 2009 Document type: Article Affiliation country: Country of publication: